MDCE OTC
Medical Care Technologies Inc.
1W: +0.0%
1M: +0.0%
3M: -50.0%
YTD: -71.4%
1Y: -75.0%
3Y: -96.1%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±4951.5%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+63.3% ▲
Gross Profit
$576K
+79.0% ▲
Operating Income
$238K
+55.6% ▲
Net Income
$231K
+53.5% ▲
EPS (Diluted)
$0.00
+0.0% ▲
EBITDA
$238K
+55.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2013 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $3M | $732K | $656K | $1M |
| YoY Growth | +0.0% | +0.0% | -78.9% | -10.3% | +63.3% |
| Cost of Revenue | $0 | $2M | $789K | $335K | $496K |
| Gross Profit | $0 | $1M | -$57K | $322K | $576K |
| Gross Margin | — | 38.3% | -7.8% | 49.0% | 53.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4M | $231K | $324K | $169K | $338K |
| Operating Expenses | $4M | $231K | $324K | $169K | $338K |
| Operating Income | -$4M | $1M | -$381K | $153K | $238K |
| Operating Margin | — | 31.7% | -52.1% | 23.3% | 22.2% |
| Interest Expense | $25K | $0 | $6K | $3K | $7K |
| Income Before Tax | -$4M | $1M | -$388K | $150K | $231K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$4M | $1M | -$388K | $150K | $231K |
| Net Margin | — | 31.7% | -52.9% | 22.9% | 21.5% |
| EPS (Diluted) | $-4.83 | $0.00 | $-0.00 | $0.00 | $0.00 |
| EBITDA | -$4M | $1M | $0 | $153K | $238K |
| Shares Outstanding | 901923 | 3.21B | 3.21B | 3.31B | 3.25B |